Dialysis PPO

DialysisPPO, headquartered in Malvern, PA, was founded in 2006 to help self-funded employer group health plans manage the extremely high cost of chronic ESRD dialysis claims. Because Medicare does not become primary payer for roughly 33 months, dialysis providers often bill self-funded plans at rates exceeding 3000% of Medicare allowable. DialysisPPO's patented program (US Patent #8457982) modifies plan documents to create benefit instruments enabling savings of up to 80-85% on dialysis claims. The program is marketed to health plans, TPAs, brokers, and stop-loss/MGU partners, reporting over $315 million in cumulative client savings.